The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19

Title
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
Authors
Keywords
SARS-CoV-2, Infection, COVID-19, Coronavirus, Autoimmunity, Rheumatic, Immunosuppressant. IL-1, IL-6, Biologics, DMARDs, tDMARDs
Journal
JOURNAL OF AUTOIMMUNITY
Volume 111, Issue -, Pages 102468
Publisher
Elsevier BV
Online
2020-04-18
DOI
10.1016/j.jaut.2020.102468

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now